Aequs Ltd Raises Rs 650 Crore Through Promoter Warrant Allotment

Total consideration stands at Rs 6,499,999,819.50, with 50% upfront payment received.
Post-conversion, promoter stake increases from 14.99% to 18.40%.

Reader Takeaway: Promoter-led capital infusion boosts liquidity for growth, though full warrant exercise will dilute existing shareholder equity.

What just happened

Aequs Ltd has officially allotted 28,071,690 warrants to Mellwood Trustee Services Private Limited, acting as the trustee for the Melligeri Private Family Foundation. These warrants are priced at Rs 231.55 each, which includes a premium of Rs 221.55 over the Rs 10 face value. The company has already collected the mandatory 50% upfront payment of approximately Rs 325 crore.

Why this matters

This capital injection demonstrates direct promoter support for the company's financial health and expansion plans. By opting for a warrant route, the promoters have provided immediate liquidity to the firm while setting a multi-year timeline for full equity integration. The move effectively locks in capital for strategic use over the next three years.

What changes now

Upon the eventual conversion of these warrants, the company's total paid-up share capital will expand from 670,665,635 shares to 698,737,325 shares. Investors should monitor this as a structural change to the equity base. The warrants carry no voting rights until they are converted into equity shares, and the issuance is subject to standard SEBI (ICDR) lock-in requirements.

What to track next

Shareholders should track the utilization of the Rs 650 crore infusion toward specific operational goals or debt reduction. Additionally, the conversion exercise date, set for on or before December 31, 2027, remains the final milestone for this transaction.